Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patrizia Bottoni
Observed names:
Bottoni, Patrizia,
P BOTTONI,
P Bottoni,
P. Bottoni
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic
Observed institutions:
University of Siena,
Università Cattolica del Sacro Cuore,
University of Cagliari,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
Sapienza University of Rome
show all 6
ORCID:
0000-0001-5427-8903
Observed ORCID:
0000-0001-5427-8903
OpenAlex ID:
A5016201118
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects
2015
·
Maria Antonietta Isgrò
, Patrizia Bottoni
, et al.
·
Advances in experimental medicine and biology
·
664
CA 19-9: Biochemical and Clinical Aspects
2015
·
Salvatore Scarà
, Patrizia Bottoni
, et al.
·
Advances in experimental medicine and biology
·
399
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects
2015
·
Patrizia Bottoni
, Roberto Scatena
·
Advances in experimental medicine and biology
·
209
Glycolytic enzyme inhibitors in cancer treatment
2008
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
Expert Opinion on Investigational Drugs
·
186
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic
2007
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
American Journal of Physiology-Cell Physiology
·
186
Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks
2009
·
R. Scatena
, P. Bottoni
, et al.
·
Current Medicinal Chemistry
·
98
Advances in Mitochondrial Medicine
2012
·
Scatena, Roberto
, Giardina, Bruno
, et al.
·
Advances in experimental medicine and biology
·
86
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential
2005
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
Expert Opinion on Investigational Drugs
·
84
Mitochondrial respiratory chain dysfunction, a non-receptor-mediated effect of synthetic PPAR-ligands: biochemical and pharmacological implications
2004
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
Biochemical and Biophysical Research Communications
·
81
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole-C2 and/or -C4 Substitutions on Biological Activity
2004
·
Antonello Mai
, Silvio Massa
, et al.
·
Journal of Medicinal Chemistry
·
67
An update on pharmacological approaches to neurodegenerative diseases
2006
·
Roberto Scatena
, Giuseppe E Martorana
, et al.
·
Expert Opinion on Investigational Drugs
·
66
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds through Structure-Based Drug Design and Docking Studies,
2004
·
Rino Ragno
, Antonello Mai
, et al.
·
Journal of Medicinal Chemistry
·
55
Mitochondria, PPARs, and Cancer: Is Receptor‐Independent Action of PPAR Agonists a Key?
2008
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
PPAR Research
·
52
PDF
Exploring the connection unit in the HDAC inhibitor pharmacophore model: Novel uracil-based hydroxamates
2005
·
Antonello Mai
, Silvio Massa
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
52
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines: A PPAR-Independent Mechanism for a Peroxisome Proliferator
2003
·
R. Scatena
, P. Bottoni
, et al.
·
Chemical Research in Toxicology
·
48
Cancer stem cells: the development of new cancer therapeutics
2011
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
Expert Opinion on Biological Therapy
·
44
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications
2012
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
42
Mitochondrial Dysfunction by Synthetic Ligands of Peroxisome Proliferator Activated Receptors (PPARs)
2004
·
Roberto Scatena
, Giuseppe Martorana
, et al.
·
IUBMB Life
·
41
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy
2010
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
PROTEOMICS - CLINICAL APPLICATIONS
·
40
Rutin Protects Fibroblasts from UVA Radiation through Stimulation of Nrf2 Pathway
2023
·
Elisabetta Tabolacci
, Giuseppe Tringali
, et al.
·
Antioxidants
·
37
PDF
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative
2017
·
Tiziana Alberio
, Luisa Pieroni
, et al.
·
Journal of Proteome Research
·
36
Bezafibrate as differentiating factor of human myeloid leukemia cells
1999
·
R Scatena
, G Nocca
, et al.
·
Cell Death and Differentiation
·
36
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line
2023
·
Francesca Sciandra
, Patrizia Bottoni
, et al.
·
International Journal of Molecular Sciences
·
29
PDF
Mitochondria, ciglitazone and liver: A neglected interaction in biochemical pharmacology
2007
·
Roberto Scatena
, Patrizia Bottoni
, et al.
·
European Journal of Pharmacology
·
28
Mitochondrial Damage and Metabolic Compensatory Mechanisms Induced by Hyperoxia in the U-937 Cell Line
2004
·
Roberto Scatena
, Irene Messana
, et al.
·
BMB Reports
·
27
PDF
Show more works
View as search
Works count:
52
Citation count:
2,911
H-index:
25
I10-index:
37
Year
Topic
Type